We demonstrate here a cardiac tissue-engineering strategy addressing multicellular organization, integration into host myocardium, and directional cues to reconstruct the functional architecture of heart muscle. Microtemplating is used to shape poly(2-hydroxyethyl methacrylate-co-methacrylic acid) hydrogel into a tissue-engineering scaffold with architectures driving heart tissue integration. The construct contains parallel channels to organize cardiomyocyte bundles, supported by micrometer-sized, spherical, interconnected pores that enhance angiogenesis while reducing scarring. Surfacemodified scaffolds were seeded with human ES cell-derived cardiomyocytes and cultured in vitro. Cardiomyocytes survived and proliferated for 2 wk in scaffolds, reaching adult heart densities. Cardiac implantation of acellular scaffolds with pore diameters of 30-40 μm showed angiogenesis and reduced fibrotic response, coinciding with a shift in macrophage phenotype toward the M2 state. This work establishes a foundation for spatially controlled cardiac tissue engineering by providing discrete compartments for cardiomyocytes and stroma in a scaffold that enhances vascularization and integration while controlling the inflammatory response.
T o date, most cell-based strategies for cardiac repair inject cell suspensions directly into injured myocardium. Studies show that 50-90% of injected cells are lost by extrusion (1) and that ∼90% of remaining cells die within 1 wk of implantation (2) . Another class of cell-based therapies creates organized tissue constructs in vitro that can be conditioned before myocardial implantation. A scaffold system scaled to address diffusion limitations of static culture may enhance cell delivery by facilitating cell retention and survival. The ideal scaffold would provide compartmentalization, organizing cardiomyocytes within the scaffold into anisotropic fibers before implantation. This ideal scaffold also would provide void spaces for vasculature and stroma. Hence, the engineered construct would create macroscopic tissue that is structurally analogous to native tissue and would facilitate host integration.
The ability of cardiomyocytes to self-aggregate and survive in suspension culture led several groups to engineer tissue constructs of cells only (3) (4) (5) or of cells and extracellular matrix proteins (6) (7) (8) . Scaffolds may promote oriented tissue architectures that facilitate diffusion-based mass transfer to reduce the ischemic injury often encountered in cell aggregates or cell transplantation (9) . A scaffold can also promote survival and integration by enhancing neovascularization while minimizing fibrotic encapsulation (10) . Preliminary results suggested that a synthetic scaffold of spherical, interconnected, and tightly controlled pore sizes (30-40 μm in diameter) can vascularize rapidly in vivo with reduced fibrotic response (10, 11) . This porous scaffold can be fabricated to impose structural organization, such as cardiomyocytes into aligned fibers for electrical propagation and synchronous contraction (12) . Mechanical matching of the scaffold to host myocardium can permit load transfer to grafted cardiomyocytes to stimulate maturation and contractile coupling while minimizing tissue damage. In this study, a bimodal scaffold architecture provides parallel channels to develop cardiomyocyte muscle bundles in vitro and also to develop a surrounding sphere-templated, interconnected porous network for improved mass transfer to generate larger tissue constructs. Implantation studies show that acellular, spheretemplated, porous constructs are able to direct rapid angiogenesis and minimize fibrosis in heart muscle.
Results
Polymer Fiber Templating. We fabricated poly(2-hydroxyethyl methacrylate-co-methacrylic acid) (pHEMA-co-MAA) hydrogel scaffolds with parallel channels by polymer fiber templating (13) ( Fig. 1 A and B) . Porous channel walls were interconnected to a spherical pore network using microsphere templating (10) . Fabricated constructs resembled the structure and hierarchical organization of native myocardium. Channel size and spacing were controlled by varying the dimensions of the template fiber (45-to 150-μm diameter). We chose the smallest diameter compatible with reliable cell seeding, 60 μm, to alleviate mass transfer issues within the channel. Channel spacing of 60 μm was selected to allow introduction of pores ranging from 20-40 μm. In this configuration ( Fig. 1 A and B) , channels account for 25% of scaffold volume; the remaining 75% is a porous network of ∼60% void space.
Polymer Mechanics. Hydrogel mechanical properties can be tuned by cross-linking. Here, the elastic modulus of the solid polymer (155 ± 14 kPa) is similar to that of rat myocardium (590 ± 22 kPa) (14) , whereas porous constructs (12 ± 6 kPa) are one order of magnitude lower than myocardial tissue and two orders of magnitude below myocardial scar tissue (4,700 ± 1,400 kPa) (14) . We reasoned that tuning the scaffold modulus below that of myocardium would facilitate mechanical stimulation of engrafted cells in vivo while minimizing diastolic dysfunction associated with stiff infarct scar tissue.
High-Density Scaffold Seeding. Scaffolds initially were seeded with primary chicken embryonic-derived cardiomyocytes (∼20-25% cardiomyocytes). This model showed we could seed constructs at high cell densities ( Fig. 1 C and D) . Immunostaining against sarcomeric myosin, a striated muscle marker, showed that cardiomyocytes predominantly occupied the channels (Fig. 1E) , whereas nonmyocytes migrated into the porous network and scaffold edge. Nonmyocyte proliferation choked off oxygen and nutrients to cardiomyocytes, limiting their viability to within ∼150 μm of the construct surface.
Our human embryonic stem cell (hESC) differentiation protocol yielded cell preparations of 10-65% cardiac purity that were enhanced by Percoll gradient centrifugation. In contrast to the noncardiomyocyte-dominated constructs of chick-derived cardiomyocytes, scaffolds seeded with hES-derived cardiomyocytes (hESC-CM) became enriched with cardiomyocytes. In every experiment, nonmyocytes declined over 5-d culture in serum-free medium, resulting in predominantly cardiomyocytes (∼95% β-myosin heavy chain-positive) organized within scaffold channels. Thus, porous channel walls were free of cells and available for mass transfer (Fig. 1F ). Enhanced mass transfer by segregation of cardiomyocytes and reduction of the noncardiomyocyte population allowed culture of larger constructs with minimal core death. Cells remained viable up to 300 μm from the scaffold edge under static culture as shown by live/dead staining (Fig. 1H) . Cardiomyocytes expressed the contractile proteins β-myosin heavy chain (Fig. 1F ) and troponin T (Fig. 1G) . These embryonicstage cardiomyocytes did not fully assemble sarcomeres but still contracted with sufficient force to deform the polymer scaffold (Movie S1).
Density of seeded β-myosin heavy chain-positive cardiomyocytes was determined from sections of several constructs. Although limited to the channels (25% construct volume), hESC-CM density (42 ± 10 × 10 (15) . The small size of hESC-CM relative to already hypertrophied adult cardiomyocytes permitted such high loadings. Construct cardiomyocyte density may increase over time, because hESC-CM maintain their proliferative capacity for at least 2 wk in culture (Fig. S1 ).
Myocardial Response to Acellular Constructs. In vivo studies were performed to evaluate the impact of pore size on fibrous encapsulation and vascularization of collagen-modified pHEMA-co-MAA hydrogels in cardiac tissue. Previously, our group showed that fibrous encapsulation and vascularization are sensitive to pore size for s.c. implants in mice (10) . The current studies examined such effects for myocardial implants in both athymic nude and immunocompetent rats. A 4-wk time point was used for histological analysis to understand long-term consequences of implants, because the acute and chronic inflammatory responses to biomedical implants subside by 3 wk (16, 17) .
Representative images of the myocardial response to 30-μm pore constructs in the nude rat are shown in Fig. 2 A-D. H&E stain shows the construct bordered by a thin, fibrous capsule, whereas the pores and surrounding interface are filled with granulation tissue (Fig. 2 A and B) . Neovascularization was observed by immunostaining for the rat endothelial cell marker RECA-1 (Fig. 2C ). Lumen structures were found within the construct and in adjacent fibrous tissue. Implant vascularization in the nude rat was quantified by the number of RECA-1 + lumens per unit area. Fig. 2I shows that a pore size threshold exists for lumen formation that probably is a function of the throat size connecting adjacent pores, ∼40-50% of the pore size. Lumen density was statistically equivalent for 30-and 60-μm pore constructs. Macrophages (MΦ) also were present, confirmed by anti-CD68 immunostaining (Fig. 2D ). Although MΦ dominated the construct surface, the spherical pores appeared to inhibit foreign body giant cell formation.
Fibrous encapsulation was examined using Masson's trichrome to detect collagen deposition ( Fig. 2 E-H ). This stain confirmed the formation of granulation/fibrous tissue within the porous network. Collagen capsule thickness correlated with pore size, so that 20 μm ≈ 30 μm < 60 μm ≈ solid in the nude rat (Fig. 2J ). This effect was confirmed in the Sprague-Dawley rat (Fig. S2) .
The above observations prompted inquiry into the functionality and mechanism of neovascularization within the scaffolds. In this case, acellular scaffolds of a wider pore size range, up to 80 μm, were implanted into the myocardium of immunocompetent Sprague-Dawley rats for 4 wk. To test functionality of neovasculature, we perfused the rats before they were killed with a biotinylated lectin that binds vessel walls and later was detected by immunostaining (Fig. 3A) . Density of perfused vessels, quantified over entire implant sites, was significantly higher in the implants with pore sizes of 40 and 80 μm (Fig. 3D) . Observation of a pore-size threshold for perfusion is consistent with the threshold for lumen formation in the nude rat model. Fidelity of the biotinylated lectin as a marker of perfusion was confirmed by colocalization of the biotinylated lectin and endothelial cells (Fig. 3B) . Additionally, vessels with a smooth muscle layer were identified within the scaffold by double staining for endothelial (RECA-1) and smooth muscle cells (α-smooth muscle actin) (Fig. 3C) . Because most endothelial structures were perfused with the lectin, and maturation of vessels was evident, these findings suggest functional neovascularization. Thus, we demonstrate that constructs with a 30-to 40-μm pore size achieve maximal vascularization and minimal fibrous encapsulation.
Mechanistically, we examined whether increased neovascularization coincided with a shift in MΦ polarity. Based on the large number of MΦ at the implant site and their known role in directing the foreign body reaction (FBR) (17), we hypothesized that scaffold architecture could impact MΦ activation to the proinflammatory M1 state or the prohealing M2 state (18) . MΦs expressing M1 and M2 markers in the scaffold were quantified by triple-label immunofluorescence. CD68 was used as a pan-MΦ marker. Nitric oxide synthase 2 (NOS2) and MΦ mannose receptor (MMR) were representative markers for the M1 and M2 activation states, respectively (18) (19) (20) (Fig. 4 A-D were found for all porous implants (P < 0.05 versus nonporous). This increased MMR expression, a marker of M2 polarization, suggests a shift toward a prohealing phenotype and may explain the enhanced neovascularization seen for porous scaffolds.
Discussion
We set out to produce a scaffold to promote bundled orientation of cardiomyocytes, increased mass transfer, enhanced neovascularization, and integration with myocardial tissue. We fabricated a biologically analogous scaffold with channel domains for cardiomyocytes and spherical pore domains for mass transfer and invading vasculature, MΦ, and stroma. Sizing of this bimodal, rodshaped scaffold was based on reported models of mass transfer for cardiac constructs (21) and our empirical observations. A minimum channel diameter of 60 μm was required to seed cardiomyocytes reliably in a 2-mm-long channel by iterative centrifugation. Cell confinement within the 60-μm channel promoted cardiomyocyte aggregation. Initial experiments using chicken embryonic cardiomyocytes showed that these bimodal scaffolds could be seeded with a high cell density. For this mixed cell population of 20-25% cardiomyocytes, the less-migratory cardiomyocytes principally remained in channels, whereas noncardiomyocytes migrated throughout the porous network. Cardiomyocytes have a high affinity for each other, with increased survival and formation of interconnected networks when cultured at high densities. Although pore space was allocated for mass transfer, nonmyocyte overgrowth limited culture of chick cardiomyocyte constructs to 1 wk.
Unexpectedly, most nonmyocytes in hESC-derived preparations died off after culturing in serum-free media, leaving a construct composed of ∼95% cardiomyocytes, regardless of initial heterogeneity. This die-off resulted in interstices free of cells for improved mass transfer and cell survival up to 300 μm into the scaffold. Cells survived >2 wk at this depth under static culture conditions and without oxygen carriers. Importantly, this scaffold design resulted in discrete channels containing physiologically relevant densities of hESC-CM. Furthermore, hESC-CM expressed the contractile proteins β-myosin heavy chain and troponin T. As expected for early embryonic cardiomyocyte development, we did not see widespread sarcomeric organization. Despite the absence of mature sarcomeres, networks of cardiomyocytes, estimated at 20% of the construct volume, generated sufficient contractile force to deform the constructs in vitro. We expect a more organized contractile apparatus to form as hESC-CM mature toward an adult phenotype. Future studies will evaluate the role of mechanical stimulation in maturation and sarcomeric organization by application in vitro or after natural stimulation upon implantation in the heart. Our approach builds on a few central concepts in cardiac tissue engineering. Spatial control was introduced by McDevitt et al. (22, 23) . High densities of cardiomyocytes were obtained by relying on self-aggregation of cardiomyocytes, the basis for scaffoldfree systems (3) (4) (5) (6) (7) (8) . We used a synthetic scaffold designed to organize the cardiomyocytes and facilitate mass transfer (21, (24) (25) (26) (27) (28) . Our approach differs from previous scaffold-based attempts in that regions were designed to exclude cardiomyocytes. Cell organization into distinct realms, with separation for mass transfer, permitted the formation of larger constructs. Cell densities similar to those in the adult human heart were realized despite the relatively small volume for cardiomyocytes. Moreover, the ability of hESC-CM to proliferate (Fig. S1 ) (29) may compensate for cell death expected during the transition from in vitro culture to the in vivo environment. Formation of a dense, organized cardiomyocyte network within the channels was encouraging, although additional aspects of the construct remain to be optimized. We predict that scaffold degradation (14) with kinetics timed for revascularization will facilitate host-graft contact, cardiomyocyte expansion and hypertrophy, and cardiomyocyte integration for electromechanical coupling and force generation.
Cardiac implantation of acellular constructs verified the feasibility of using bimodal pHEMA-co-MAA scaffolds for in vivo cell delivery and established a size threshold necessary for vessel lumen formation and perfusion. Beyond this threshold, pore size over the range studied here had no statistically significant impact on vascularization. The density of functional vessels within implants with pore sizes of 40 and 80 μm was similar to previous reports of prevascularized cardiac implants (30) without complications of tricell (cardiomyocyte, endothelial cell, fibroblast) sourcing and seeding. Previous studies by our group found that s.c.-implanted, sphere-templated materials with larger pores (∼90-160 μm) led to more fibrosis and less vascularity (10) . Constrained by the small size of the rat heart, myocardial response to larger pores (>80 μm) was not determined. Pore size effects observed here relate to previous studies in which 10-to 45-μm pores filled with fibrohistiocytic tissue, whereas pores >45 μm filled with organized fibrous tissue (31, 32) . These earlier studies used materials with broad pore-size distributions (only average pore size was reported), making conclusions about the effects of pore size difficult. In contrast, the sphere-templated materials used here had tightly controlled pore and interconnect sizes.
MΦ phenotype was explored as a mechanism by which scaffold architectures enhanced neovascularization. MΦ orchestrate the FBR by releasing cytokines and chemical mediators to attract other cells (endothelial cells, MΦ, fibroblasts) and to break down the implant (17) . These MΦ are activated over a proposed polarization continuum (M1/M2 polarization) (18) (19) (20) . At one end, M1-polarized MΦ are proinflammatory; at the other extreme, M2-polarized MΦ are considered antiinflammatory, marked by the release of growth factor and tissue remodeling (19, 33) . Here we find that MΦ activation depends on biomaterial architecture in addition to previously implicated biomaterial chemistry and bioactivity (34) (35) (36) .
Representative markers of the M1 and M2 activation states, NOS2 and MMR, respectively, were used to elucidate the activation state of implant-associated MΦ. A majority of the activated MΦ expressed NOS2, indicating the biomaterial activates proinflammatory pathways. MMR expression increased significantly at porous implants, and this increase tracked with improved neovascularization for implants with pores >20 μm. The increase in MMR expression resulted in a large fraction of MΦ of a mixed phenotype at porous implants, showing that a defined porous architecture turns on supposed prohealing pathways in these NOS2 + MΦ. Previous in vivo studies demonstrated concurrent expression of M1 and M2 markers (37) , and enhanced expression of M2 markers has been associated with improved outcomes for implanted biologic scaffolds (34) . Our results are consistent with these studies: MΦ activation to an M2 phenotype coincides with enhanced neovascularization. Future studies will examine additional macrophage-activation markers and cytokine expression to determine where scaffold-associated macrophages lie on the polarization continuum and to what extent they direct neovascularization.
This work describes a proangiogenic, bimodal scaffold for cardiac tissue engineering. The scaffold was tailored to accommodate the propensity of cardiomyocytes to aggregate within aligned channels optimized to attain constructs approximating in vivo cell densities. In acellular cardiac implants, the sphere-templated architecture maximized neovascularization while minimizing fibrosis. We developed a model system for ongoing studies on hESC-CM behavior and cardiac tissue engineering. Rod-like scaffold constructs could feasibly be implanted in infarcted human hearts using minimally invasive catheter introduction systems.
Materials and Methods
Scaffold Fabrication. Bimodal scaffolds having interconnected spherical pore regions and channels with high aspect ratios were templated from poly (methyl methacrylate) (PMMA) beads and polycarbonate (PC) core/PMMA optical fiber (POF) shell according to published methods (10, 13) with slight modifications (SI Materials and Methods). The template was infiltrated with monomer solution (2-HEMA and 5% MAA) using tetraethylene glycol dimethacrylate as a cross-linker and Irgacure 651 (Ciba) as a UV initiator (38) . The PC/PMMA template was solubilized in dichloromethane over 5 d; then the hydrogel was rehydrated to water and surface derivatized with rat tail collagen I (BD) using ethyl(dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) chemistry.
Cardiomyocyte Isolation. Cardiomyocytes were isolated from day 11 chicken embryos as previously described (39) (SI Materials and Methods). HESC-CM were obtained using protocols developed in our laboratories (40) (SI Materials and Methods).
Cell Seeding of Constructs. Gels, 2 mm thick, were punched out using a 3-mm biopsy punch, with channels parallel to the punch. With the gel in the biopsy punch, 5 million cells in 50 μL of medium were loaded on top of the gel. The construct was placed in a 1.7-mL Eppendorf tube and centrifuged for 5 min at ∼200 × g. The construct was washed with medium to remove and collect cells that had not entered channels. This process was repeated three times. Constructs were removed from the biopsy punch and cut into strips ∼300-800 μm thick × 2 mm long. At the appropriate time, samples were fixed and histologically analyzed (SI Materials and Methods).
Digital Volumetric Imaging. Chick cardiomyocyte-seeded scaffolds were fixed and subject to whole-mount fluorescent staining using acridine orange for cell nuclei (red) and eosin Y for cytoplasm (green). Samples were processed and sectioned in a Digital Volumetric Imager (Microscience Group) (41) . Sections were taken and the block imaged at 1-μm intervals with a 10× objective at ∼0.9 μm/voxel using 460-500 nm excitation light and emission filters for >600 nm (red) or 510-590 nm (green). Images were reconstructed into a 3D representation using ResView version 3.2 (Microsciences Group). Scaffolds displayed nonspecific acridine orange/eosin staining, resulting in high-intensity red/green fluorescence (yellow upon overlay). Overlap of acridine orange also was seen in the cell cytoplasm, resulting in the red appearance of most cellular material (SI Materials and Methods). Acellular Myocardial Implants. All animal experiments adhered to federal guidelines and were approved by the University of Washington Animal Care and Use Committee. Athymic nude rats (Rh-rnu/rnu) and Sprague-Dawley rats were used to evaluate myocardial implantation of acellular, collagen-modified pHEMA-co-MAA scaffolds of varying pore size (SI Materials and Methods). At 28 d, animals were killed with pentobarbital; hearts were removed, rinsed in PBS, and fixed in methyl Carnoy's solution. Sprague-Dawley rats, used in analysis of vessel perfusion and MΦ activation, were anesthetized with isoflurane and injected with 300 μg biotinylated tomato lectin (Vector Labs) 28 d after implantation and 10 min before they were killed. Hearts were vibratomed to 1-mm-thick sections, routinely processed, paraffin embedded, and sectioned for histological analysis. FBR was evaluated by H&E and trichrome stains; immunohistochemistry was performed to detect endothelial cells, macrophages, and smooth muscle cells; vessel functionality was assessed by detection of perfused biotinylated lectin (SI Materials and Methods). Images were acquired on a Nikon TE200 inverted or an E800 upright microscope in brightfield or epifluorescence using Metamorph software.
Statistical Analysis. Data are presented as means ± 95% confidence intervals. Quantification of histological sections was performed with 40× images taken over the entire implant area on two or three sections per animal (n = 3 or 4). A paired t test was used to establish significance.
